Stay updated with breaking news from Aipsc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Rating) have been given an average rating of “Buy” by the seven ratings firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price […]
Century Therapeutics (NASDAQ:IPSC – Get Rating) is one of 259 public companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its competitors? We will compare Century Therapeutics to similar companies based on the strength of its risk, institutional ownership, analyst recommendations, earnings, dividends, profitability and valuation. Profitability This […]
Equities researchers at Roth Capital began coverage on shares of Century Therapeutics (NASDAQ:IPSC – Get Rating) in a research note issued on Friday, The Fly reports. The brokerage set a “buy” rating on the stock. Several other equities research analysts have also recently commented on IPSC. HC Wainwright began coverage on Century Therapeutics in a […]
The AIPSC was inaugurated by K K Shailaja, former Health Minister, Kerala. Other speakers included Dr Sabyasachi Chatterjee, President AIPSN, Indumathi D and Rajesh Joshi, writer and poet.
Century Therapeutics (NASDAQ:IPSC – Get Rating) is one of 259 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare Century Therapeutics to related companies based on the strength of its risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Insider and […]